IDE clinical trial for artificial cervical disc completes enrollment

Synergy Spine Solutions has enrolled the last patient in its investigational device exemption (IDE) clinical trial. The 1-Level Synergy Disc …

ASCO 2023: Precigen reports positive early data for CAR-T therapy

New early data suggests Precigen Therapeutics’s CAR-T therapy PRGN-3005 could decrease tumour burden in advanced ovarian cancer. In Phase I data …

Synlogic begins Phase III trial of SYNB1934 for phenylketonuria

US-based biotechnology firm Synlogic has begun a Phase III trial of SYNB1934 for the treatment of phenylketonuria (PKU), a rare …

FogPharma doses first patient in colorectal cancer drug trial

US-based biopharmaceutical company FogPharma has dosed the first patient in its first-in-human Phase I/II clinical trial of FOG-001, a TCF-blocking …

Imbria completes patient enrolment in trial of nHCM therapy

US-based pharmaceutical company Imbria Pharmaceuticals has finished enrolling patients in its IMPROVE-HCM Phase II clinical trial of ninerafaxstat for non-obstructive …